SNY
Sanofi·NASDAQ
--
--(--)
--
--(--)
5.84 / 10
Netural
Analyst coverage is limited to one UBS neutral rating, with a 100% historical win rate and weighted score 4.16. Fund‑flow score is 7.52 (good); overall inflow is positive, though large‑cap investors show a slight outflow. Sentiment remains neutral.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-16
InstitutionUBS
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of SNY?
- SNY holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.84/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
